Webb7 mars 2024 · TearSolutions is a privately held biotechnology company focused on the discovery, development and commercialization of novel therapies for the treatment of … Webb07.12.2024 Moscow, Russia, December 7, 2024 – Pharmstandard International, S.A. and Middleland Capital's Virginia Tech Carilion (VTC) Innovation Fund co-led the $8.5M Series B financing of TearSolutions, Inc. Also participating were most of TearSolutions' existing investors, including Santen Ventures, Inc. Proceeds will be used to advance Lacripep TM, …
Tearsolutions, Inc. Company Profile - Dun & Bradstreet
WebbTearSolutions is a pharmaceutical company that specializes in providing medical solutions for dry eyes. The company is driven by its mission is to develop a novel replacement … Webb24 nov. 2024 · Charlottesville, Va. – November 24, 2024 – TearSolutions, Inc., a privately held developer of Lacripep TM , a naturally occurring replacement therapy for the … dayton freight job reviews
TearSolutions Expands and Establishes Advisory Boards and …
WebbTearSolutions Inc. Apr 2013 - Jul 20247 years 4 months Fundraising Oversight of clinical development of Lacripep (TM), a novel natural … WebbTearSolutions Inc. 639 följare på LinkedIn. Naturally Restoring Ocular Health TearSolutions Inc. is a Delaware Corporation based in Charlottesville, VA. The company has successfully completed a well-powered 204 patient Phase II Proof of Concept clinical trial for the treatment of the signs and symptoms of dry eye in primary Sjögren’s … WebbCharlottesville, Va. – Sept. 28, 2024 – TearSolutions, Inc., a privately held developer of a potentially disruptive therapy for the treatment of Dry Eye Disease (DED) called Lacripep … dayton freight interline points